Robert G. Uzzo MD, MBA, FACSDeputy Chief Clinical Office and Director, Surgical Services, Fox Chase Cancer Center/Jeanes Hospital; Chairman, Department of Surgical Oncology, Fox Chase Cancer Center; G. Willing “Wing” Pepper Professor of Urological Oncology, Fox Chase Cancer Center/Temple University; Chair, Fox Chase/Einstein Urologic Institute, Philadelphia, Pennsylvania
Dr. Uzzo graduated summa cum laude from Union College and attended Cornell University Medical College. He completed general surgical training followed by urologic surgical training at New York Hospital - Cornell Medical Center and Memorial Sloan-Kettering Cancer Center. He was an American Foundation for Urological Diseases Scholar in Urological Oncology and completed both Oncological and Renal Transplantation Fellowships at the Cleveland Clinic.
Dr. Uzzo is currently the Deputy Chief Clinical Officer; Director of Surgical Services, Fox Chase Cancer Center/Jeanes Hospital; Chairman of the Department of Surgical Oncology, Fox Chase Cancer Center; and the G. Willing “Wing” Pepper Professor of Urological Oncology at Fox Chase Cancer Center/Temple University. He is also the Chair of the Fox Chase/Einstein Urologic Institute. He maintains an active, funded laboratory investigating kidney and prostate cancer. His clinical interests include minimally invasive urological oncology and renal malignancies. He has authored over 300 peer-reviewed articles in urologic oncology.
Recent Contributions to PracticeUpdate:
- Oncologic Outcomes of Robot-Assisted Partial Nephrectomy vs Percutaneous Cryoablation for Renal Masses
- Comparing Off-Clamp and On-Clamp Robot-Assisted Partial Nephrectomy
- Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous mRCC Receiving Sunitinib
- Renal Cell Carcinoma and Brain Metastasis: Questioning the Dogma of Role for Cytoreductive Nephrectomy
- Prevalence of Benign Pathologic Findings After Partial Nephrectomy With Preoperative Imaging Patterns
- Tumor–Parenchyma Interface and Long-Term Oncologic Outcomes After Robotic Tumor Enucleation for Sporadic RCC
- Clinical Complications in Renal Biopsy Using Two Different Needle Gauges
- Contemporary Surgical Management of Renal Oncocytoma
- Multiple Growth Periods Predict Unfavorable Pathology in Patients With Small Renal Masses
- Routine Renal Tumor Biopsy Is Associated With Lower Rates of Benign Histology on Resection for Small Renal Masses